News

Three-year EMBARK data show ELEVIDYS slows functional decline in ambulatory Duchenne patients, extending earlier 2-year efficacy findings.

More than half of infants with myelomeningocele experience sleep-disordered breathing before hospital discharge, with prematurity driving risk.

A study found that a deep learning model using baseline fundus images can accurately predict myopia progression and high myopia risk.

A study found that individuals with ADHD traits in childhood had increased odds of physical multimorbidity and disability by midlife.

Eye-tracking technology revolutionizes autism diagnosis, enabling earlier detection and intervention for children, enhancing clinical efficiency and accuracy.

A study found that nonmedical childhood vaccine exemptions have increased significantly across US counties since 2010.

FDA accepted centanafadine NDA for priority review, supported by phase 3 trials showing efficacy in children, adolescents, and adults with ADHD.

A study found significant gaps in sudden unexpected death in epilepsy awareness and risk management.

AAP updated guidance supports therapeutic hypothermia for term infants with moderate to severe HIE, emphasizing early initiation and specialized care.

Caregivers with food insecurity balance prior lifestyle experiences, trust in newer medications, and deeply held beliefs about child health when considering GLP-1 receptor agonists.

The AAP released its 2026 childhood immunization schedule, maintaining evidence-based vaccine recommendations and expanding guidance across routine, catch-up, and risk-based care.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Findings from phase 3 SHORE and COAST 2 trials showed amlitelimab met key efficacy end points in moderate to severe atopic dermatitis, supporting planned regulatory submissions.

AnnaLynn M. Williams, PhD; and Kevin Krull, PhD, discuss accelerated biologic aging in childhood cancer survivors.

FDA-cleared Flowflex Plus 4-in-1 home test detects RSV, influenza A/B, and COVID-19 in adults and children as young as 6 months.

Researchers identified 5 distinct classifications of youth suicide, revealing that nearly half of cases had no prior clinical contact or documented risk.

Results from a large US cohort study found no association between community water fluoridation and birth weight, providing reassurance about exposure during pregnancy.

Influenza antiviral use among hospitalized US children declined during the late COVID-19 pandemic despite guideline recommendations.

Children who require high-flow nasal cannula therapy during hospitalization for bronchiolitis are more likely to be diagnosed with asthma later in childhood.

Data suggest that higher social media use in childhood is associated with increased inattentive ADHD symptoms over time.

A national survey found most patients with chronic inflammatory skin disease rely on flare-based care and report concerns about long-term topical steroid use.

Analysis of nearly 900 million hours of monitored infant sleep shows rapid stabilization of sleep patterns in the first year of life.

In a recent study, caregiver experiences, trust, and family values shaped decisions about GLP-1 medications for children with obesity.

FDA grants 510(k) clearance to a portable neonatal incubator designed to support thermoregulation and keep preterm infants close to mothers.

Long-acting injectable HIV treatment given every 2 months was safe, well tolerated, and strongly preferred by adolescents in a recent study.

Vimal H. Prajapati, MD, discusses the latest roflumilast cream data from the INTEGUMENT-PED trial for pediatric atopic dermatitis.

A large 2026 meta-analysis found no association between prenatal paracetamol (acetaminophen) use and autism, ADHD, or intellectual disability in children.

Adolescents with HIV reported strong preference, viral suppression, and favorable safety outcomes after switching to long-acting injectable treatment.